Dr. Martens CEO buys £85,600 in shares after full year 2026 profit growth
Dr. Martens has announced that its Chief Executive Ije Nwokorie has purchased company shares worth about £85,600, following a recent boost in profit.
Last Friday Nwokorie purchased 112,500 ordinary shares at a cost of £0.761 each, with the transaction disclosed via the the London Stock Exchange today, 16 June.
Separately, a disclosure on 16 June showed that both Nwokorie and Chief Financial officer Giles Wilson had also increased their holdings through Dr. Martens' HMRC-approved Share Incentive Plan.
Each Executive purchased 202 partnership shares at 74.37p per share on 11 June and received a matching allocation of 202 free shares. That scheme is an all-employee programme allowing staff to buy shares from salary, with the company providing matching shares.
The transaction signals a boost in confidence by the CEO in the future of the UK-listed footwear brand, which recently reported a 61% rise in adjusted pre-tax profit for the financial year ending 29 March 2026.
The company commented on the results that its full year 2025 had focused on stabilising the business, while full year 2026 centred on pivoting to a consumer-first model. This included reducing clearance activity across both DTC and wholesale operations, restructuring leadership teams and simplifying the operating model to improve accountability.
The next financial year will mark the beginning of the “scale” phase of Dr. Martens' “Levers for Growth” strategy, which is structured around three pillars: stabilise, pivot and scale.
Nwokorie's appointment as CEO was first announced in April 2024. Before joining Dr. Martens, he held a senior director role at Apple for more than six years.
